1-5 of 5
Arijit Nag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)

Jeevan Kumar, Rajat Pincha, Vivek S Radhakrishnan, Naveed Tamboli, Arijit Nag, Dibakar Podder, Debranjani Chattopadhyay, Saurabh Jayant Bhave, Sreya Das, Mayur Parihar, Asish Rath, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak Kumar Mishra, Mammen Chandy, Reena Nair
Journal: Blood
Blood (2023) 142 (Supplement 1): 6713.
https://doi.org/10.1182/blood-2023-186903
Published: 2023
Journal Articles

Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Jorge E. Cortes, Tapan Saikia, Dong-Wook Kim, Yesid Alvarado, Franck E. Nicolini, Krishnakumar Rathnam, Navin Khattry, Sachin Punatar, Jane F. Apperley, Aude Charbonnier, Michael Deininger, Hugues de Lavallade, Nikki Granacher, Carlo Gambacorti-Passerini, Alessandro Lucchesi, Michael Mauro, Peter Vandenberghe, Gregor Verhoef, Andrew R. Whiteley, Arijit Nag, Shashikant Apte, Siu-Long Yao, Sandeep Inamdar, Ruchika Irene Dillu, Jayasree Sreenivasan, Geetanjali Chimote
Journal: Blood
Blood (2022) 140 (Supplement 1): 205–207.
https://doi.org/10.1182/blood-2022-166452
Published: 2022
Journal Articles

Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Vivek S Radhakrishnan, Naveed Tamboli, Shreya Das, Jeevan Kumar Garg, Arijit Nag, Saurabh J Bhave, Mayur Parihar, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak K Mishra, Reena Nair, Mammen Chandy
Journal: Blood
Blood (2021) 138 (Supplement 1): 2752.
https://doi.org/10.1182/blood-2021-151718
Published: 2021
Journal Articles

Induction Mortality in Acute Myeloid Leukemia: A 9 Year Retrospective Study from a Tertiary Care Centre in a Low-Middle Income Country Setting

Vivek S Radhakrishnan, Sandeep A Pattnaik, Arunima Bhadhuri, Vasundhara Raina, Payal Mandal, Saurabh J Bhave, Jeevan Kumar Garg, Arijit Nag, Sushant Vinarkar, Mayur Parihar, Deepak K Mishra, Reena Nair, Mammen Chandy
Journal: Blood
Blood (2021) 138 (Supplement 1): 4388.
https://doi.org/10.1182/blood-2021-154152
Published: 2021
Journal Articles

An Update of Safety and Efficacy Results from Phase 1 Dose-Escalation and Expansion Study of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI), in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing Prior TKI Therapies

Jorge E. Cortes, Tapan Saikia, Dong-Wook Kim, Yesid Alvarado, Franck E. Nicolini, Krishnakumar Rathnam, Navin Khattry, Jane F Apperley, Michael W. Deininger, Hugues de Lavallade, Aude Charbonnier, Nikki Granacher, Carlo Gambacorti-Passerini, Alessandro Lucchesi, Michael J. Mauro, Peter Vandenberghe, Gregor Verhoef, Andrew R. Whiteley, Arijit Nag, Vivek S Radhakrishnan, Shashikant Apte, Siu-Long Yao, Sandeep Inamdar, Jayasree Sreenivasan, Ruchika Irene Dillu, Geetanjali Chimote
Journal: Blood
Blood (2021) 138 (Supplement 1): 309.
https://doi.org/10.1182/blood-2021-152548
Published: 2021